Latest Strategy Changes News

N1 Holdings reports a steady start to FY26 with a $375,000 net profit and robust cash flow, driven by its SME lending operations and enhanced by AI technology.

AJ Lucas Group Limited reported a robust start to FY26, driven by a significant UK dispute settlement and improved Australian operations. The company’s liquidity and operational upgrades position it well despite ongoing challenges.

Foresta Group Holdings finalises a $4.6 million insurance settlement and progresses key contracts for its Kawerau Plant, reporting a solid cash position as it deepens forestry sector partnerships.

Openn Negotiation Ltd remains suspended from ASX trading but has secured interest-free loans from its major shareholder to support working capital as it explores strategic options post-DOCA.

I Synergy Group Limited reported a mixed quarterly cash flow for Q3 2025, highlighting ongoing operational cash outflows but securing financing to extend its runway to just under two quarters.

Entertainment Rewards Ltd reported a 2.2% revenue increase in Q1 FY26, driven by strong membership growth and Card Linked Offers, while securing an additional $3 million loan to support its strategic initiatives.

EZZ Life Science Holdings reported a 25% drop in Q1 receipts, driven by seasonal softness and campaign timing, while accelerating its US market entry and launching three new health supplements.

Belararox Limited has kicked off its 2025/26 field season in Argentina and progressed drilling in Botswana’s Kalahari Copper Belt, supported by a recent A$8.5 million capital raise that strengthens its financial position.

Eneco Refresh Limited reported a solid 9% year-on-year revenue increase in Q1 FY26, propelled by strong gains in its plastics division and HYDR8 custom label water products across key Australian regions.

Westar Resources reported strategic tenement adjustments and promising assay results at its Mageye prospect during the September 2025 quarter, while maintaining a cautious cash position and continuing exploration efforts.

Echo IQ Limited has advanced its EchoSolv heart failure solution towards FDA submission, driven by a landmark clinical validation study and a sharp rise in US platform adoption. Strategic partnerships and international expansion efforts underscore the company’s growing footprint in cardiology AI.

Papyrus Australia has taken a major step towards commercialisation by signing a $4.2 million binding Terms Sheet with TBS Mining Solutions and progressing a high-volume production facility in Vietnam. The company also secured a $250,000 government grant and restructured its leadership to support growth.